- Home
- VRNS vs MIR Comparison
VRNS vs MIR Comparison
Compare VRNS & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNS
- MIR
- Stock Information
- Founded
- VRNS 2004
- MIR 2005
- Country
- VRNS United States
- MIR United States
- Employees
- VRNS N/A
- MIR N/A
- Industry
- VRNS Computer Software: Prepackaged Software
- MIR Industrial Machinery/Components
- Sector
- VRNS Technology
- MIR Technology
- Exchange
- VRNS Nasdaq
- MIR Nasdaq
- Market Cap
- VRNS 4.4B
- MIR 5.0B
- IPO Year
- VRNS 2014
- MIR N/A
- Fundamental
- Price
- VRNS $54.73
- MIR $19.86
- Analyst Decision
- VRNS Buy
- MIR Strong Buy
- Analyst Count
- VRNS 16
- MIR 4
- Target Price
- VRNS $58.38
- MIR $22.25
- AVG Volume (30 Days)
- VRNS 1.8M
- MIR 2.8M
- Earning Date
- VRNS 07-29-2025
- MIR 07-31-2025
- Dividend Yield
- VRNS N/A
- MIR N/A
- EPS Growth
- VRNS N/A
- MIR N/A
- EPS
- VRNS N/A
- MIR 0.05
- Revenue
- VRNS $595,168,000.00
- MIR $886,000,000.00
- Revenue This Year
- VRNS $14.92
- MIR $6.76
- Revenue Next Year
- VRNS $16.53
- MIR $7.55
- P/E Ratio
- VRNS N/A
- MIR $431.33
- Revenue Growth
- VRNS 14.29
- MIR 7.88
- 52 Week Low
- VRNS $36.53
- MIR $9.11
- 52 Week High
- VRNS $60.58
- MIR $22.80
- Technical
- Relative Strength Index (RSI)
- VRNS 60.90
- MIR 38.41
- Support Level
- VRNS $52.77
- MIR $20.79
- Resistance Level
- VRNS $58.41
- MIR $22.80
- Average True Range (ATR)
- VRNS 1.69
- MIR 0.69
- MACD
- VRNS 0.31
- MIR -0.13
- Stochastic Oscillator
- VRNS 57.21
- MIR 36.29
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.